166 related articles for article (PubMed ID: 12841152)
21. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention.
Hunter DJ
Epidemiology; 1993 Jan; 4(1):63-72. PubMed ID: 8420583
[TBL] [Abstract][Full Text] [Related]
22. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
[TBL] [Abstract][Full Text] [Related]
23. HIV prevention before HAART in sub-Saharan Africa.
Marseille E; Hofmann PB; Kahn JG
Lancet; 2002 May; 359(9320):1851-6. PubMed ID: 12044394
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus infection and AIDS in east Africa: challenges and possibilities for prevention and control.
Mhalu FS; Lyamuya E
East Afr Med J; 1996 Jan; 73(1):13-9. PubMed ID: 8625855
[TBL] [Abstract][Full Text] [Related]
26. HIV/AIDS and debt crises: threat to human survival in sub-Saharan Africa.
Odhiambo W
Med Confl Surviv; 2003; 19(2):142-7. PubMed ID: 12868516
[TBL] [Abstract][Full Text] [Related]
27. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
[TBL] [Abstract][Full Text] [Related]
28. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
29. Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions.
Hoenigl M; Chaillon A; Mehta SR; Smith DM; Graff-Zivin J; Little SJ
J Infect; 2016 Nov; 73(5):476-484. PubMed ID: 27521468
[TBL] [Abstract][Full Text] [Related]
30. Gender dynamics and the challenges for HIV prevention.
Mbizvo MT
Cent Afr J Med; 1996 Dec; 42(12):351-4. PubMed ID: 9164019
[TBL] [Abstract][Full Text] [Related]
31. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
Sante; 1997; 7(2):115-25. PubMed ID: 9273118
[TBL] [Abstract][Full Text] [Related]
32. Fighting HIV/AIDS: is success possible?
Okware S; Opio A; Musinguzi J; Waibale P
Bull World Health Organ; 2001; 79(12):1113-20. PubMed ID: 11799443
[TBL] [Abstract][Full Text] [Related]
33. AIDS epidemic in Malawi: shaking cultural foundations.
Chirwa I
Netw Res Triangle Park N C; 1993 May; 13(4):31-2. PubMed ID: 12344876
[TBL] [Abstract][Full Text] [Related]
34. Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.
Pattanaphesaj J; Teerawattananon Y
BMC Public Health; 2010 Jul; 10():401. PubMed ID: 20604975
[TBL] [Abstract][Full Text] [Related]
35. Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations.
Craig AP; Thein HH; Zhang L; Gray RT; Henderson K; Wilson D; Gorgens M; Wilson DP
J Int AIDS Soc; 2014; 17(1):18822. PubMed ID: 24572053
[TBL] [Abstract][Full Text] [Related]
36. Comparative costs and cost-effectiveness of behavioural interventions as part of HIV prevention strategies.
Hsu J; Zinsou C; Parkhurst J; N'Dour M; Foyet L; Mueller DH
Health Policy Plan; 2013 Jan; 28(1):20-9. PubMed ID: 22411881
[TBL] [Abstract][Full Text] [Related]
37. Allocating HIV prevention resources: a tool for state and local decision making.
Richter A; Hicks KA; Earnshaw SR; Honeycutt AA
Health Policy; 2008 Sep; 87(3):342-9. PubMed ID: 18342388
[TBL] [Abstract][Full Text] [Related]
38. Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group.
Moses S; Plummer FA; Ngugi EN; Nagelkerke NJ; Anzala AO; Ndinya-Achola JO
AIDS; 1991 Apr; 5(4):407-11. PubMed ID: 1905555
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
[TBL] [Abstract][Full Text] [Related]
40. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
